PSI AND BIOMARIN NAMED FINALISTS FOR 2016 PHARMATIMES STRATEGIC PARTNERSHIP COMPETITION

Zug, Switzerland, April 5, 2016 – PSI CRO, a global full-service contract research organization, and BioMarin, a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders, were named as a finalist for the 2016 International Clinical Researcher of the Year competition in the Strategic Partnership Team category.

This prestigious multi-stage competition organized by PharmaTimes was created in 1999 as a unique opportunity for pharmaceutical companies, CROs and academia to test their professionalism and expertise in clinical research.

As an alliance team, PSI CRO and BioMarin were nominated as finalists, having demonstrated principles of successful clinical trial collaboration. This achievement is a result of the productive partnership between the two companies over time.

The finals will take place on 21 April 2016 at Novo Nordisk, 3 City Place, Beehive Ring Road, Gatwick, West Sussex RH6 0PA, UK. The winners of the PharmaTimes International Clinical Researcher of the Year 2016 will be announced at a gala dinner and awards ceremony on 12 May 2016 at the Lancaster London hotel, Lancaster Terrace, London W2 2TY, UK.

About BioMarin:

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company’s portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.BMRN.com. Information on BioMarin’s website is not incorporated by reference into this press release.

Media Contact:
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451

About PSI CRO:

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com

PSI Inquiries to:
Barbara Breen
PSI CRO
Marketing@psi-cro.com
+1 847 202 1120


Can’t find what you’re looking for? Contact us

MEET OUR PEOPLE

ACRP Annual Meeting
April 28-May 7, 2017
Visit the Site  
View More

TESTIMONIALS

Outstanding job PSI has done in accessing and providing us with requested source documents. With the thousands of emails zipping around each month, they never lose track of a single request; and are able to respond immediately to our questions. There are just not words enough to express our gratitude and thanks. OUTSTANDING JOB!"
Pharma consultant, USA, March 2016
The performance of the entire team thus far has been exemplary. They have consistently met the established timelines, thoughtfully navigated obstacles along the way, and have allowed us to start off to a successful “roll-over” beginning. The team has shown a commitment to teamwork and collaboration in their efforts."
From a pharma client, USA, March 2016
A fantastic accomplishment. Team work at its finest. Great job."
Clinical Scientific Director, USA, February 2016
Read More

PRESS RELEASES

PSI TAKES TOP SPOT IN GLOBAL CRO SURVEY FOR SECOND TIME

PSI Takes Top Spot In Global CRO Survey For Second Time
2017 CenterWatch Investigator Site Survey Ranks 12 CROs Worldwide
PSI CRO, Zug, Switzerland, 3 April 2017 – PSI CRO has received top honors in the bi-annual CenterWatch Global Investigator Site Survey 2017, for the second time in a row. The … Read More »

Read More

GET IN TOUCH

  • This field is for validation purposes and should be left unchanged.